PA 1050040

Drug Profile

PA 1050040

Alternative Names: PA-040; PA-1050040

Latest Information Update: 03 Apr 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Panacos Pharmaceuticals Inc
  • Class Antivirals
  • Mechanism of Action Capsid protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 25 Jul 2007 Data presented at the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS-2007) added to the Viral Infections antimicrobial activity and pharmacokinetics sections
  • 28 Feb 2007 Phase-I clinical trials in HIV infections treatment in USA (PO)
  • 28 Dec 2006 Preclinical trials in HIV infections treatment in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top